Who is Responsible for Severe Liver Damage Side Effects?

Strattera (atomoxetine) Lawsuits and Lawyers handling Strattera lawsuits

What is Strattera?

On December 17, 2004 the FDA issued a new warning for Strattera (atomoxetine) a drug approved to treat attention deficit hyperactivity disorder (ADHD) in adults and children. Strattera’s original professional product labeling or package insert, is being updated to include a bolded warning about the potential for severe liver toxicity following two patient reports of acute liver damage.

The new warning advises of severe liver damage that may progress to liver failure, potentially resulting in death or the need for a liver transplant in some patients. The labeling also notes that the number of actual cases of severe liver injury is unknown because of under-reporting of post-marketing adverse events.

Strattera is no magic pill and will still have side effects just like stimulants used to treat ADHD patients. As with any new drug, how Strattera will work is unknown as is its long-term side effects. Strattera does not seem to impact hyperactivity as much as the stimulant medications. People might need to use a stimulant ADHD medication alongside Strattera, which defeats the argument that you can avoid stimulant medication. Strattera’s longer action time causes dosage complications that can extend from months to a year. Patients should not be prescribed Strattera if they are already taking the psychotropic drugs Prozac and Paxil.

If you or a family member has developed any of the symptoms associated with potential liver toxicity, talk to your doctor immediately and contact an expert Strattera lawyer for a free inquiry. You may be eligible for a Strattera lawsuit or fill out the below form.